Clinical medicine Press Release

Title Picture
12/15/2017 - 10:30
Raccoon in Rehoboth Positive for Rabies; Public Health Warns Residents of Kings Creek Area
Delaware State Government's picture
Delaware State ...
12/15/2017 - 08:17
Teva Announces Exclusive Launch of Generic Viread in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
12/14/2017 - 20:39
First-in-class ERK1/2 Inhibitor Safe, Shows Early Efficacy in Patients With Advanced Solid Tumors
American Association for Cancer Research's picture
American Associ...
12/14/2017 - 14:26
Recommended Radiation Omitted From Breast Conservation Therapy for Some Women
Fox Chase's picture
Fox Chase
12/14/2017 - 13:43
Wistar Scientists Identify Mechanism of Impaired Dendritic Cell Function that Weakens Immune and Therapeutic Response to Cancer
Wistar Institute's picture
Wistar Institute
12/14/2017 - 11:07
Morristown Medical Center Leads New Jersey in Aortic Heart Valve Replacement Without Surgery
Atlantic Health System's picture
Atlantic Health...
12/14/2017 - 10:52
Atlantic Digestive Health Institute Designated First-and-Only IBD Center of Excellence in New Jersey by Atlantic ACO
Atlantic Health System's picture
Atlantic Health...
12/14/2017 - 03:24
First Hospitals in the World Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
Accuray's picture
12/14/2017 - 01:54
UK DRI invests 1.5m million into Huntingdons Disease
Alzheimer's Research UK's picture
Alzheimers Research
12/13/2017 - 21:12
Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active Psoriatic Arthritis
Pfizer's picture
12/13/2017 - 05:03
GMU Scientists Develop Testing that could Help Detect TB Early
Virginia Biotechnology Association's picture
12/13/2017 - 00:20
Gut feeling spurs doctor to re-examine evidence on urinary tract infections in patients with spinal cord injury
University of British Columbia's picture
12/12/2017 - 23:37
DPH Announces First Flu Death of 2017-2018 Season
Delaware State Government's picture
Delaware State ...
12/12/2017 - 23:25
Delaware Health and Social Services's picture
12/12/2017 - 23:18
FDA Approves New Pfizer Biosimilar
Pfizer's picture
12/12/2017 - 22:25
Yuma Sector Border Patrol Agents Find Meth in SUV
U.S. Customs and Border Protection's picture
12/12/2017 - 21:02
Spectrum Pharmaceuticals Highlights Two Oral Presentations on FOLOTYN (pralatrexate injection) at the 59th Annual Meeting of the American Society of Hematology (ASH)
Spectrum's picture
12/12/2017 - 19:16
Preliminary Data from Servier and Pfizers UCART19 Product Candidate Shows High Complete Remission Rate Across Two Phase I Adult and Pediatric Acute Lymphoblastic Leukemia Trials
Cellectis's picture
12/12/2017 - 18:06
Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
Daiichi Sankyo's picture
Daiichi Sankyo
12/12/2017 - 17:43
Immune cell therapy results are 'landmark moment' in lymphoma treatment
Cancer Research UK's picture
Cancer Research UK
12/12/2017 - 17:14
Meth Smuggler Nabbed by San Luis CBP Officers
U.S. Customs and Border Protection's picture
12/12/2017 - 14:07
Bangladesh moves to protect Rohingya children from diphtheria
United Nations Children's Fund's picture
12/12/2017 - 13:36
U.S. Food And Drug Administration Extends Action Date For XELJANZ (Tofacitinib) Supplemental New Drug Application In Ulcerative Colitis By Three Months
Pfizer's picture
12/12/2017 - 11:50
GSK achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US
GlaxoSmithKline's picture
12/12/2017 - 11:00
FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome
Food and Drug Administration's picture
12/12/2017 - 08:31
DARZALEX (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible
Johnson and Johnson's picture
Johnson and Johnson
12/12/2017 - 08:10
Teenagers with incontinence are at risk of underachieving at secondary school
 University of Bristol's picture
University of B...
12/12/2017 - 06:52
Late-Breaking Clinical Trials Signal New Therapeutic Options for Many Patients in the Near Term
American Society of Hematology's picture
American Societ...
12/12/2017 - 05:29
Myriad's BRACAnalysis CDx Test Effectively Identified Metastatic Breast Cancer Patients with Improved Outcomes from Pfizer's PARP Inhibitor, Talazoparib
Myriad's picture
12/12/2017 - 01:31
How privacy policies affect genetic testing
Massachusetts Institute of Technology's picture
12/11/2017 - 22:15
7:30 AM-9:00 AM
Multiple Myeloma Research Foundation's picture
12/11/2017 - 20:47
How to care for children with chickenpox
American Academy of Dermatology's picture
12/11/2017 - 19:39
Border Patrol Discovers Meth in Vehicles Gas Tank
U.S. Customs and Border Protection's picture
12/11/2017 - 18:35
Early data evaluated subcutaneous delivery of DARZALEX in relapsed or refractory multiple myeloma (oral presentation;
Johnson and Johnson's picture
Johnson and Johnson
12/11/2017 - 12:55
A new weapon against bone metastasis? Princeton lab develops antibody to fight cancer
Princeton University's picture
Princeton University
12/11/2017 - 12:47
GSK presents promising new data for priority BCMA asset from its emerging Oncology pipeline at 59th ASH meeting
GlaxoSmithKline's picture
12/11/2017 - 11:50
Researchers Find Simpler Way to Deposit Magnetic Iron Oxide onto Gold Nanorods
North Carolina State University's picture
12/11/2017 - 11:37
Teva Dismisses Litigation After Mylan Wins U.S. Court Ruling Related to Teva's Cold Filtration Patents for Copaxone 40 mg/mL
Mylan's picture
12/11/2017 - 11:28
Omalizumab improves efficacy of oral immunotherapy for multiple food allergies
National Institutes of Health's picture
12/11/2017 - 10:29
Results of Phase 1b/2 Dose Regimen Optimization Studies for ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Presented at American Society of Hematology (ASH) Meeting
Alexion's picture
12/11/2017 - 08:47
Dr. James Kochenderfer from the NIH presented the latest data on the anti-B-cell maturation antigen (BCMA) CAR-T cell therapy bb2121 (
Multiple Myeloma Research Foundation's picture
12/11/2017 - 08:32
Rexahn Pharmaceuticals Presents New Preclinical Data on Supinoxin at the 2017 San Antonio Breast Cancer Symposium
Rexahn Pharmaceuticals's picture
Rexahn Pharmace...
12/11/2017 - 07:09
Genomic Health Presents New Data Demonstrating Value of Oncotype DX to Optimize Breast Cancer Outcomes and Reduce Treatment Burden throughout Disease Continuum
Genomic's picture
12/11/2017 - 05:49
Scientists discover possible master switch for programming cancer immunotherapy
Scripps Research's picture
Scripps Research
12/11/2017 - 05:42
Janssen Submits Supplemental New Drug Application to FDA Seeking New Indications for XARELTO (rivaroxaban) for Patients with Chronic Coronary and/or Peripheral Artery Disease (CAD/PAD)
Johnson and Johnson's picture
Johnson and Johnson
12/11/2017 - 04:54
Death receptors new markers for type 2 diabetes and cardiovascular disease
Lund University's picture
12/11/2017 - 04:49
Juno Therapeutics and Celgene Corporation Release Additional Data from TRANSCEND Trial of JCAR017 in Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
Celgene's picture
12/11/2017 - 00:24
Atezolizumab plus Avastin Significantly Improves Progression Free Survival Compared with Sunitinib in PD-L1 Positive Patients for the First-line Treatment of Advanced Renal Cell Carcinoma in the IMmotion151 Study
Chugai's picture
12/10/2017 - 23:29
Phase III IMmotion151 study showed Roches Tecentriq (atezolizumab) and Avastin (bevacizumab) reduced the risk of disease worsening or death for the initial treatment of certain people with advanced kidney cancer
Rocheusa's picture
12/10/2017 - 15:24
New Smartphone Case Offers Blood Glucose Monitoring on the Go
California Institute for Telecommunications and In...'s picture
12/10/2017 - 14:50
Low-dose treatment with interleukin-2 across multiple studies shows benefits in chronic graft-versus-host disease
Dana Farber's picture
Dana Farber
12/10/2017 - 14:35
Study shows combining chemotherapy with targeted drug boosts response in chronic lymphocytic leukemia
Dana Farber's picture
Dana Farber
12/10/2017 - 11:35
Autologous Stem Cell Transplant at Key Point Remains Most Effective Therapy for Younger Mantle Cell Lymphoma Patients
Fox Chase's picture
Fox Chase
12/10/2017 - 11:22
Sequencing offers clues to progression toward multiple myeloma
Dana Farber's picture
Dana Farber
12/10/2017 - 11:19
CAR T-Cell Therapies Drive Outcomes in Lymphoma, Myeloma
American Society of Hematology's picture
American Societ...
12/10/2017 - 10:39
Multiple Myeloma Research Foundation
Multiple Myeloma Research Foundation's picture
12/10/2017 - 09:49
Phase II Data Showed Genentechs Investigational Polatuzumab Vedotin Plus Bendamustine and Rituxan (BR) Increased Complete Response Rates Compared to BR Alone in Previously Treated Aggressive Lymphoma
Genentech's picture
12/10/2017 - 07:21
Rapid Responses, Few Adverse Effects Seen with Targeted Agent in Phase 1 Trial in Rare Blood Disorder
Dana Farber's picture
Dana Farber
12/10/2017 - 06:14
Targeted Therapies Show Promise for Improving Outcomes Across a Spectrum of Hematologic Malignancies
American Society of Hematology's picture
American Societ...
12/10/2017 - 05:42
Phase II data showed Roches investigational polatuzumab vedotin plus bendamustine and MabThera/Rituxan (BR) increased complete response rates compared to BR alone in previously treated aggressive lymphoma
Rocheusa's picture